222 related articles for article (PubMed ID: 31675723)
21. Radiotherapy after gross-total resection and subtotal resection of spinal chordoma: a SEER database analysis of overall survival outcomes.
Gendreau J; Kuo CC; Mehkri Y; Chakravarti S; Lu B; Lubelski D; Redmond KJ; Bettegowda C; Mukherjee D
J Neurosurg Spine; 2023 Sep; 39(3):411-418. PubMed ID: 37327146
[TBL] [Abstract][Full Text] [Related]
22. Epidemiologic and survival trends in adult primary bone tumors of the spine.
Kerr DL; Dial BL; Lazarides AL; Catanzano AA; Lane WO; Blazer DG; Brigman BE; Mendoza-Lattes S; Eward WC; Erickson ME
Spine J; 2019 Dec; 19(12):1941-1949. PubMed ID: 31306757
[TBL] [Abstract][Full Text] [Related]
23. The surgical management of sacral chordomas.
Schwab JH; Healey JH; Rose P; Casas-Ganem J; Boland PJ
Spine (Phila Pa 1976); 2009 Nov; 34(24):2700-4. PubMed ID: 19910774
[TBL] [Abstract][Full Text] [Related]
24. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.
Molina CA; Ames CP; Chou D; Rhines LD; Hsieh PC; Zadnik PL; Wolinsky JP; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2014 Sep; 21(3):348-56. PubMed ID: 24926926
[TBL] [Abstract][Full Text] [Related]
25. Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma.
Houdek MT; Rose PS; Hevesi M; Schwab JH; Griffin AM; Healey JH; Petersen IA; DeLaney TF; Chung PW; Yaszemski MJ; Wunder JS; Hornicek FJ; Boland PJ; Sim FH; Ferguson PC;
J Surg Oncol; 2019 Jun; 119(7):856-863. PubMed ID: 30734292
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment of sacral chordoma: survival and prognostic factors.
Ruosi C; Colella G; Di Donato SL; Granata F; Di Salvatore MG; Fazioli F
Eur Spine J; 2015 Nov; 24 Suppl 7():912-7. PubMed ID: 26458933
[TBL] [Abstract][Full Text] [Related]
27. Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers.
Radaelli S; Stacchiotti S; Ruggieri P; Donati D; Casali PG; Palmerini E; Collini P; Gambarotti M; Porcu L; Boriani S; Gronchi A; Picci P
Spine (Phila Pa 1976); 2016 Jun; 41(12):1049-1057. PubMed ID: 27054448
[TBL] [Abstract][Full Text] [Related]
28. Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomas.
Banfield W; Ioakeim-Ioannidou M; Goldberg S; Ahmed S; Schwab JH; Cote GM; Choy E; Shin JH; Hornicek FJ; Liebsch NJ; Chen YE; MacDonald SM; DeLaney TF
Radiother Oncol; 2022 Jun; 171():139-145. PubMed ID: 35429502
[TBL] [Abstract][Full Text] [Related]
29. Chordoma: long-term follow-up after radical photon irradiation.
Catton C; O'Sullivan B; Bell R; Laperriere N; Cummings B; Fornasier V; Wunder J
Radiother Oncol; 1996 Oct; 41(1):67-72. PubMed ID: 8961370
[TBL] [Abstract][Full Text] [Related]
30. Disease outcomes for skull base and spinal chordomas: a single center experience.
Ahmed R; Sheybani A; Menezes AH; Buatti JM; Hitchon PW
Clin Neurol Neurosurg; 2015 Mar; 130():67-73. PubMed ID: 25590662
[TBL] [Abstract][Full Text] [Related]
31. Predictive Value of Preoperative Magnetic Resonance Imaging Findings for Survival and Local Recurrence in Patients Undergoing En Bloc Resection of Sacral Chordomas.
Zuckerman SL; Amini B; Lee SH; Rao G; Tatsui CE; Rhines LD
Neurosurgery; 2019 Dec; 85(6):834-842. PubMed ID: 30541143
[TBL] [Abstract][Full Text] [Related]
32. Spinal stereotactic body radiotherapy following intralesional curettage with separation surgery for initial or salvage chordoma treatment.
Lockney DT; Shub T; Hopkins B; Lockney NA; Moussazadeh N; Lis E; Yamada Y; Schmitt AM; Higginson DS; Laufer I; Bilsky M
Neurosurg Focus; 2017 Jan; 42(1):E4. PubMed ID: 28041314
[TBL] [Abstract][Full Text] [Related]
33. Surgical management of chordoma: A systematic review.
Denaro L; Berton A; Ciuffreda M; Loppini M; Candela V; Brandi ML; Longo UG
J Spinal Cord Med; 2020 Nov; 43(6):797-812. PubMed ID: 30048230
[No Abstract] [Full Text] [Related]
34. Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy.
Holliday EB; Mitra HS; Somerson JS; Rhines LD; Mahajan A; Brown PD; Grosshans DR
Spine (Phila Pa 1976); 2015 Apr; 40(8):544-9. PubMed ID: 25627289
[TBL] [Abstract][Full Text] [Related]
35. A review of the surgical management of sacral chordoma.
Kayani B; Hanna SA; Sewell MD; Saifuddin A; Molloy S; Briggs TW
Eur J Surg Oncol; 2014 Nov; 40(11):1412-20. PubMed ID: 24793103
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in the operative management of dedifferentiated sacral chordomas.
Kayani B; Sewell MD; Hanna SA; Saifuddin A; Aston W; Pollock R; Skinner J; Molloy S; Briggs TW
Neurosurgery; 2014 Sep; 75(3):269-75; discussion 275. PubMed ID: 24867206
[TBL] [Abstract][Full Text] [Related]
37. Sacral chordoma: 40-year experience at a major cancer center.
York JE; Kaczaraj A; Abi-Said D; Fuller GN; Skibber JM; Janjan NA; Gokaslan ZL
Neurosurgery; 1999 Jan; 44(1):74-9; discussion 79-80. PubMed ID: 9894966
[TBL] [Abstract][Full Text] [Related]
38. Oncologic and functional outcome following sacrectomy for sacral chordoma.
Hulen CA; Temple HT; Fox WP; Sama AA; Green BA; Eismont FJ
J Bone Joint Surg Am; 2006 Jul; 88(7):1532-9. PubMed ID: 16818979
[TBL] [Abstract][Full Text] [Related]
39. Decision making in primary sacral tumors.
Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA
Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810
[TBL] [Abstract][Full Text] [Related]
40. Surgical treatment of sacral chordomas combined with transcatheter arterial embolization.
Yang H; Zhu L; Ebraheim NA; Liu J; Shapiro A; Castillo S; Liu X; Tang T
J Spinal Disord Tech; 2010 Feb; 23(1):47-52. PubMed ID: 20084025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
